New York Angels
VC Fund
New York, United States
New York Angels is a VC fund in New York focused on Software and Health Care. New York Angels is one of the largest and most active angel investment organizations.Founded in 2004 as the successor organization to the NYNMA (New York New Media Association) Angel Investor Program, New York Angels is a membership organization of over 110 active angel investors and early stage venture capital funds. The group meets monthly toscreen and present early stage technology companies, and its members have invested over $100 million since 2002 into over 90 ventures. In April of 2017, PItchbook identified New York Angels as #3 in their list of the 8 top VCs funding seed rounds of New York-based companies.Among the NYA membership are nationally known angel investors including Esther Dyson and David S. Rose. The group has one full-time staff, reporting to an 11 person Board of Directors chaired by Brian S. Cohen. Dr. Elizabeth Lindsey is currently Program Director of New York Angels. Since 2012, the membership has increased by 66% and investment activity has grown by over 215%. New York Angels concentrates on early stage investments in the range of $100,000 - $1,000,000, although it has led deals as large as $2 million. It receives over 2,200 financing applications annually, from which it selects 12-16 companies each month for an in-person screening, where all members of New York Angels are invited to attend. The group meets again for an Investment Breakfast at the end of the month, where 2-4 opportunities present to the membership with a goal to close their current investment round within two months.The group is considered a leader in the growing field of organized angel investing. It was the first member of the national Angel Capital Association, hosted the ACA Summit conference in 2006, and was the initial test group for the now-standard gust (Angelsoft) funding platform.Membership as an investor in New York Angels is by invitation only, and members are required to commit to investing at least $50,000 annually in early stage technology deals, in addition to the group's $3,500 annual membership dues.Requests for funding for entrepreneurial ventures may be self-submitted through the group's website. New York Angels charges no fees to entrepreneurs.
- Total investments:
- 378
- Last investment:
- Lead investor:
- 32%
- Fund size:
- $2.4M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries New York Angels invests in
Stages New York Angels invests in
Countries New York Angels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 14 contacts → | |||
Round size
- Seed
- $325k–$5M
- Series A
- $1.1M–$10M
- Series B
- $2M–$15M
Investment Focus
Industry
- Software 29 (8%)
- Health Care 17 (4%)
- Mobile 11 (3%)
- Information Technology 11 (3%)
- Artificial Intelligence 10 (3%)
Stage
- Seed 61 (16%)
- Series A 21 (6%)
- Series B 14 (4%)
- Funding Round 14 (4%)
- Angel 5 (1%)
Country
- United States 103 (27%)
- Israel 1 (0%)
- United Kingdom 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Edith Simchi-Levi
Member
|
Member | Total investments: 1 | Find email | |
Alan Patricof
Partner
|
Partner | Total investments: 37 | Find email | |
Angelo Abdela
Director & Treasurer
|
Director & Treasurer | Total investments: 0 | Find email | |
|
Arve Hanstveit
Member
|
Member | Total investments: 0 | Find email | |
David S. Rose
Founder & Chairman Emeritus
|
Founder & Chairman Emeritus | Total investments: 24 | Find email | |
| See all 14 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kind Design uses 3D Printing technology to print living seawalls that mimic coral reefs and mangroves, hosting biodiversity and improving the quality of water. | $10M / Seed / Jul 16, 2026 | ||
| Phase3D develops in-situ monitoring technology for additive manufacturing, providing real-time, layer-by-layer inspection of 3D printing processes. Their flagship product, Fringe, uses structured light to detect and quantify anomalies during printing, offering data in microns for quality assessment. Fringe is compatible with various industrial 3Dprinters and can be retrofitted to existing equipment. The system helps users identify issues early and take action to maintain part integrity. | $2M / Seed / May 12, 2026 | ||
| Skyfire AI develops autonomous drone systems that use artificial intelligence for mission planning, data analysis, and aerial coordination. Its platform enables object detection, real-time tracking, and adaptive flight control for use in public safety, defense, and infrastructure. The technology supports tasks such as surveillance, inspection, andsearch and rescue by providing AI-driven insights and automated mission execution, including multi-drone deployments. | $11M / Seed / Apr 28, 2026 | ||
| Hinalea Imaging is a technology company that unifies the power of digital imaging to reveal critical details about a product. | $212K / Seed / Nov 26, 2025 | ||
| RubyWell is an intelligent and automated guide that helps family caregivers regain financial stability by continuously discovering and delivering new savings, benefits, and compensation opportunities. | Seed / Nov 01, 2025 | ||
| AiM Medical Robotics developing a robotic system for use in neurosurgical procedures. The system is unique in that it is MRI compatible, allowing patients to be treated while in the MRI scanner. This gives physicians the ability to capture real-time imaging feedback to improve outcomes. Its system will help treat patients with Parkinson's,Epilepsy, Tremors, and brain cancer. | $8.1M / Series A / Sep 30, 2025 | ||
| Edokonta builds software that allows hospitals to track mobile equipment, such as IV pumps and ultrasounds. The company was founded in 2018 and based in San Diego, California. | $785K / Venture - Series Unknown / Sep 03, 2025 | ||
| Develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring. | $525K / Venture - Series Unknown / Sep 01, 2025 | ||
| Enertiv is a real estate technology company that transforms building data into asset value. Our platform streamlines building operations by digitizing the physical infrastructure of commercial real estate portfolios. We collect better data, faster and more affordably than anyone else, enabling owners and operators to eliminate waste within theirlargest and most controllable operating expenses.In addition to utilizing existing data sources, we deploy IoT devices to continuously track every critical piece of equipment, tenant space, and indoor environmental condition to enable operators to ensure peak performance of their assets around the clock. | Sep 01, 2025 | ||
| AIQ Solutions develops a medical device technology platform that revolutionizes the treatment response of patients with complex diseases.AIQ Solutions was born out of the University of Wisconsin Translational Imaging Research Program. The original founders, Robert Jeraj, PhD; Glenn Liu, MD; George Wilding, MD; and Dona Alberti, BSN, RN, hadworked together for over ten years at the University of Wisconsin Carbone Cancer Center and had decades of experience in drug development, clinical trials, and translational imaging research.From 2009 to 2015, Dr. Jeraj and Dr. Liu leveraged $8M in industry and grant funding to develop the novel methodology underlying AIQ's products. In January 2015 AIQ was incorporated. The patents protecting AIQ’s innovations were issued in October 2015 and March 2017. In April 2017 AIQ signed an exclusive license agreement with the Wisconsin Alumni Research Foundation covering both patents as well as the software code associated with QTBI. In July 2018 AIQ received US FDA 510(k) clearance for its QTxI platform, which includes the QTBI product. | Venture - Series Unknown / Sep 01, 2025 | ||
| See all 378 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does New York Angels invest in?
New York Angels invests primarily in Software, Health Care and Mobile startups, most often at Seed and Series A stage. Most of the 378 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is New York Angels's check size?
New York Angels typically joins rounds of $325k–$5M at Seed, $1.1M–$10M at Series A and $2M–$15M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds New York Angels participates in.
How do I contact New York Angels?
Public channels for New York Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at New York Angels?
The team at New York Angels includes Edith Simchi-Levi (Member), Alan Patricof (Partner) and Angelo Abdela (Director & Treasurer), among 14 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
